Purpose The study aimed to provide a comprehensive bibliometric overview of the current
scientific publications on fibroblast activation protein inhibitor (FAPI) positron emission …

Despite revolutionizing the field of oncological imaging, Positron Emission Tomography
(PET) with [18F] Fluorodeoxyglucose (FDG) as its workhorse is limited by a lack of specificity …

Objective In this study, we investigated the role of [68Ga] Ga-FAPI PET imaging in the
detection of primary and metastatic gastric signet-ring-cell carcinoma (GSRCC) and …

Objectives We aimed to compare the diagnostic and prognostic performance of [68Ga] Ga-
DOTA-FAPI-04 and [18F] FDG PET/CT in pancreatic cancer. Methods This single-center …

Purpose This study was designed to compare the performance of 68Ga-FAPI-04 and 18F-
FDG PET/CT for initial staging and recurrence detection of head and neck squamous cell …

FAPI-based radiopharmaceuticals are a novel class of tracers, mainly used for PET imaging,
which have demonstrated several advantages over [18F] FDG, especially in the case of low …

Several studies have examined the use of positron emission tomography (PET) using [68Ga]
Ga-radiolabeled fibroblast-activation protein inhibitors (FAPi) across multiple subtypes of …

Ongoing discussion within the nuclear medicine community suggests that all radionuclide
therapies (RNTs) should include posttreatment quantitative dosimetry as part of standard …

Purpose This study aimed to explore the value of [68Ga] Ga-labelled fibroblast activation
protein inhibitor ([68Ga] Ga-FAPI) positron emission tomography/computed tomography …

Cancer-associated fibroblasts (CAFs) are involved in critical aspects of head and neck
squamous cell carcinoma (HNSCC) pathogenesis, such as the formation of a tumor …